This translational, clinically oriented ebook explains in detail novel approaches to cancer immunotherapy, presents strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the ebook was published in 2015, the original chapters have been considerably updated and entirely new chapters are included on, for instance, aptamer-mediated cancer gene therapy, cancer immunoprevention-haploidentical bone marrow transplantation for pediatric malignancies, and nanoimmunotherapy.
The ebook is published as part of the three-volume Springer series Cancer Immunology, which intends to provide the latest, clinically relevant review of cancer immunology and immunotherapy. Other volumes in the series address the translational medicine context and cancer immunotherapy for organ-specific tumors. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, 2nd Edition, (PDF) will be of special value to clinical immunologists, hematologists, and oncologists.
“Several professionals will find this ebook helpful, including physicians and trainees in hematology-oncology, pathologists, immunologists, and basic scientists who study tumor cell biology. … This is a helpful resource for investigators and clinicians interested in cancer immunology and immunotherapeutics. The subject matter is current and comprehensively presented.” — George M Rodgers, Doody’s Book Reviews, February 8, 2021
NOTE: The product only includes the ebook, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers 2nd Edition in PDF. No access codes are included.